DNetPRO: A network approach for low-dimensional signatures from high-throughput data
暂无分享,去创建一个
Nico Curti | Enrico Giampieri | Gastone Castellani | Daniel Remondini | G. Levi | G. Castellani | D. Remondini | Nico Curti | E. Giampieri | G. Levi
[1] Geoffrey S Ginsburg,et al. Personalized medicine: progress and promise. , 2011, Annual review of genomics and human genetics.
[2] J. Beckmann,et al. Reconciling evidence-based medicine and precision medicine in the era of big data: challenges and opportunities , 2016, Genome Medicine.
[3] Jason Weston,et al. Gene Selection for Cancer Classification using Support Vector Machines , 2002, Machine Learning.
[4] Adam A. Margolin,et al. Assessing the clinical utility of cancer genomic and proteomic data across tumor types , 2014, Nature Biotechnology.
[5] Mirko Francesconi,et al. Overcoming resistance to conventional drugs in Ewing sarcoma and identification of molecular predictors of outcome. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] Atul J Butte,et al. Robust meta-analysis of gene expression using the elastic net , 2015, Nucleic acids research.
[7] Tiejun Tong,et al. Gene Selection Using Iterative Feature Elimination Random Forests for Survival Outcomes , 2012, IEEE/ACM Transactions on Computational Biology and Bioinformatics.
[8] E. Liebscher. A Universal Selection Method in Linear Regression Models , 2012 .
[9] T. M. Johnson. Perspective on Precision Medicine in Oncology , 2017, Pharmacotherapy.
[10] R. R. Hocking. The analysis and selection of variables in linear regression , 1976 .
[11] Aixia Guo,et al. Gene Selection for Cancer Classification using Support Vector Machines , 2014 .